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Leber congenital amaurosis (LCA), the most early-onset and severe form of all inherited retinal dystrophies, is
responsible for congenital blindness. Ten LCA genes have been mapped, and seven of these have been identiﬁed.
Because some of these genes are involved in the visual cycle, we regarded the retinal pigment epithelium and
photoreceptor-speciﬁc retinal dehydrogenase (RDH) genes as candidate genes in LCA. Studying a series of 110
unrelated patients with LCA, we found mutations in the photoreceptor-speciﬁc RDH12 gene in a signiﬁcant subset
of patients (4.1%). Interestingly, all patients harboring RDH12 mutations had a severe yet progressive rod-cone
dystrophy with severe macular atrophy but no or mild hyperopia.
Introduction
Leber congenital amaurosis (LCA), the most early-onset
and severe form of all inherited retinal dystrophies, is
responsible for congenital blindness. On the basis of the
course of the disease, two clinical subtypes have been
recognized in LCA: a severe, congenital stationary cone-
rod dystrophy and a severe yet progressive rod-cone dys-
trophy. This latter phenotype may represent the upper
extreme of the spectrum of retinitis pigmentosa (RP)
(Perrault et al. 1999; Hanein et al. 2004). A total of 10
LCA genes have been mapped, and 7 of them have been
identiﬁed—namely,
1. the retinal-speciﬁc guanylate cyclase gene (GUCY2D,
or “retGC1” [MIM 600179]) at the LCA1 locus
(17p13.1) (Perrault et al. 1996),
2. the gene encoding the 65-kDa protein speciﬁc to the
retinal pigment epithelium (RPE) (RPE65 [MIM
180069]) at the LCA2 locus (1p31) (Marlhens et al.
1997; Perrault et al. 1999),
3. the cone-rod homeobox-containing gene (CRX
[MIM 60225]) at 19q13.3 (Freund et al. 1998; Swa-
roop et al. 1999),
4. the gene encoding arylhydrocarbon receptor inter-
acting protein-like 1 (AIPL1 [MIM 604392]) at the
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LCA4 locus (17p13.1) (Sohocki et al. 2000),
5. the gene encoding retinitis pigmentosa GTPase
regulator-interacting protein 1 (RPGRIP1 [MIM
605446]) at the LCA6 locus (14q11) (Dryja et al.
2001; Gerber et al. 2001),
6. the human homologue of the Drosophila melano-
gaster gene encoding the crumbs protein (CRB1
[MIM 604210]), at 1q31 (den Hollander et al. 2001;
Lotery et al. 2001; Gerber et al. 2002), and
7. the gene encoding tubby-like protein 1 (TULP1
[MIM 602280]) at 6q21.3 (North et al. 1997; Hanein
et al. 2004).
On the other hand, the disease-causing genes remain
unknown in LCA3 (MIM 604232), linked to 14q24
(Stockton et al. 1998); LCA5 (MIM 604537), linked to
6q11-16 (Dharmaraj et al. 2000); and LCA9, linked to
1p36 (Keen et al. 2003).
Identiﬁcation of RPE65 and lecithin retinol acyltrans-
ferase (LRAT) as disease-causing genes in LCA and
childhood-onset retinal dystrophy (CSRD) prompted us
to consider proteins of the visual cycle as candidate
genes in LCA (Gu et al. 1997; Thompson et al. 2001).
For this reason, genes encoding the RPE-speciﬁc
RDH10 and RDH11 proteins and the photoreceptor-
speciﬁc genes RDH8 and RDH12–RDH14 were re-
garded as strong candidates, especially since RDH11
and RDH12 map close to LCA3 on 14q23.3 (Stockton
et al. 1998). Here we report on photoreceptor-speciﬁc
RDH12 gene mutations in a signiﬁcant subset of pa-
tients with LCA. Interestingly, all patients with LCA
carrying RDH12 mutations had severe, congenital (yet
progressive) rod-cone dystrophy, delineating the ﬁrst ge-
notype-phenotype correlation in this subtype of LCA.
640 Am. J. Hum. Genet. 75:639–646, 2004
Material and Methods
Patients
Minimum inclusion criteria for LCA were (1) severe
impairment of visual function, detected at birth or dur-
ing the ﬁrst months of life, with pendular nystagmus,
roving eye movements, eye poking, inability to follow
light or objects, and normal fundus; (2) extinguished
electroretinogram responses; and (3) exclusion of oph-
thalmological or systemic diseases sharing features with
LCA. Detailed clinical data were required for each pa-
tient—namely, (1) age at and mode of onset; (2) light
behavior since birth; (3) natural history of the visual
impairment since the ﬁrst months of life, including the
subjective impressions of the parents; (4) refraction data;
(5) ophthalmologic ﬁndings (anterior chamber and fun-
dus); (6) visual acuity (when measurable); and (7) elec-
trophysiology recordings. The course of the disease was
determined by interviewing the patients or their parents,
and a pedigree was established.
Our series of 179 unrelated patients with LCA has
been previously divided into two groups on the basis of
the clinical course of the disease (Hanein et al. 2004).
In group A, we have included the patients with congen-
ital stationary cone-rod dystrophy, and group B includes
the patients with severe yet progressive rod-cone dys-
trophy. We have previously shown that no mutation is
found in 59/179 patients belonging to group A and 35/
179 patients belonging to group B (Hanein et al. 2004).
These individuals, as well as 16 other unrelated patients
with LCA in whom no mutation has been found (group
A, ; group B, ), were included in the presentnp 7 np 9
study (group A, ; group B, ; total,np 66 np 44 np
).110
Genomic DNA was extracted from whole blood or
immortalized lymphoblast cell lines of patients, through
use of standard methods. When a mutation was iden-
tiﬁed, parents and other family members were examined,
when available. Genomic DNA of 196 unrelated healthy
individuals of French ancestry were used as controls.
Mutational Screening
The study of the LRAT and RDH genes was per-
formed on genomic DNA through use of primers de-
signed to ﬂank the splice junctions of each coding exon
(table 1). After standard PCR ampliﬁcation (conditions
available on request), products were screened for mu-
tations through use of denaturing high-performance liq-
uid chromatography (DHPLC). Heteroduplex formation
was induced by heat denaturation of PCR products at
94C for 10 min, followed by gradual reannealing from
94C to 25C over 30 min. DHPLC analysis was per-
formed with the WAVE DNA fragment analysis system
(Transgenomic). PCR products were eluted at a ﬂow rate
of 0.9 ml/min with a linear acetonitrile gradient. The
values of the buffer gradients (buffer A: 0.1 M triethyl-
ammonium acetate; buffer B: 0.1 M triethylammonium
acetate/25% acetonitrile), start and end points of the
gradient, and melting temperature predictions were de-
termined by WAVEMAKER software (Transgenomic).
Optimal run temperatures were empirically determined.
Mobile-phase temperatures were assessed, within a 5C
window above and below the suggested run tempera-
ture, on the basis of the melting proﬁle.
PCR fragments displaying DHPLC abnormal proﬁles
were further sequenced using the Big Dye Terminator
Cycle Sequencing Kit v2 (ABI Prism, Applied Biosys-
tems) on a 3100 automated sequencer.
Mutation Nomenclature
The adenine (A) of the start codon (ATG) of the RDH
cDNA was assigned as nucleotide 1 (GenBank accession
numbers: RDH8, NM_015725; RDH10, BC067131;
RDH11, BC011727; RDH12, BC025724; RDH13,
BC009881; and RDH14, BC009830).
Results
No RDH12 mutations were found in patients with LCA
presenting with congenital stationary cone-rod dystro-
phy (group A), but homozygosity or compound hetero-
zygosity for 11 distinct RDH12 mutations were found
in 8/44 patients with LCA who were affected with the
congenital severe yet progressive rod-cone dystrophy
form of the disease (group B; ﬁg. 1). Mutations included
two nonsense mutations, one splice-site mutation, seven
missense mutations, and one frameshift deletion (table
2). The frameshift deletion, a 5-bp deletion in RDH12
exon 6, was found in four of eight unrelated families of
French ancestry.
The seven missense mutations involved amino acids
highly conserved in the mouse ortholog and in the genes
RDH8 and RDH10–RDH14 (ﬁg. 2). Two of them in-
volved the histidine at position 151. In one, the mutation
changed the positively charged histidine into a negatively
charged amino acid (p.His151Asn in ﬁg. 2); in the second,
the histidine was changed into an uncharged amino acid
(p.His151Asp in ﬁg. 2). The mutations segregated with
the disease and were absent in 196 ethnically matched
control individuals (392 chromosomes).
None of the 110 patients with LCA was found to
carry LRAT, RDH8, RDH10, RDH11, RDH13, or
RDH14 gene mutations. Only some silent changes and
benign variants were identiﬁed (table 3).
Although a congenital nystagmus related to profound
visual impairment was constantly present in all patients
with LCA, it appeared retrospectively that the clinical
course of LCA in patients carrying RDH12 mutations
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Table 1
Sequences of Forward and Reverse Primers Used for the Mutation Screening of the LRAT, RDH8, and
RDH10–RDH14 Genes
GENE AND
EXON NUMBER
PRIMER SEQUENCE (5′r3′)
Forward Reverse
LRAT (3 exons, 2 coding exons):
2.1 ACCTCTCCAAGACGCCCT TGCTGGCCACTTTGACAATA
2.2 GGTGGTCTCCAACAAGCGTC GGGAAGAGAAAAGGTCAGGG
3 TCTTCTTGGGTTTAGCCACC TTTACATACAGAATACACAC
RDH8 (6 exons):
1 GGATGAATGGTCAGAGTCAG TAGGGGAGACAGTGCTGG
2 AACGCAAGATCACAGACACG TGAGGGTCTATACTCAGACC
3 GGGAGTGTCTAGAAGTAATG GGGGAGGATCAGACACTG
4 ACCCTGGAACCCACAAAGCC CCCCTTTCGATGCCACCTCC
5 GGACAAAATAGGTCAGGGAG CAACATACCTGAGCCACGTC
6 GTGGCTCAGGTATGTTGC CATCCTTTGAATTAGATGTGG
RDH10 (6 exons):
1 CCCGATTGCCGGGCTCGG GGCGCGGGGTGGAAAGAGG
2 ATGTGACTCACTTTCTGCAC TCCCAACCTTCTCATTAAGG
3 GTTTTGTGATCCTGGACTGG TCTGGTGTACTTATCACAGG
4 TTAGTTTGGTTGGAGATAGG CAGTTCCACATATTCTCC
5 GTACCCAAAATCCCATCACTC TAAGACATCGGGCAGGCATG
6 CCATGCCTGCCCGATGTC TGCTGATGTGCACTGGACTG
RDH11 (7 exons):
1 AAGCCATAGTCGGCGAGCAA CCGCAACAAGAATTCTCAAG
2 GAACCTACTGGCTGAGACAG GAATCATCATTACTGTGAGG
3 TAGATTTATAATGCCAGCTC GTTGAATCTGCCATGTTGAC
4 AAGATGTAATAGCCTTGGCT CAAGAAGCCTCAATCTGACC
5 CACGACTCCTGTCATTCCTA TGTGGCTTTTACCTGCCTCT
6 TTGGGCTATTCTGCAAAATC CCAAATTATCTCCTTTGAGC
7 TGGCAGATGGCAGACTTCAT GACGAATCTGGCAGTACACT
RDH12 (7 exons):
1 CAGGAACCTGAGCCAGAGC TTTCTCCTCTGTCAGCCTCC
2 CGTATCTTAGTGTGAGCTCG GAATTTCTAGTCAGAGCCCC
3 CCAGTCCCAAGCTCACTTAC AGGGTGGAGCAGCCACTC
4 ATTATGCAGGTCTGTTACAG CTCCACATTTACACAGTGTC
5 TCCTCTTGGCTCCCACATGC CCCAAGTTGCTGTGGACCTC
6 TGTGTATTTTGCTGCAGGAG GATGAACAGCCCAGCGAG
7 GGGACCATAAAGATTTCCAG GATCAGAGCAGGCAGGATTC
RDH13 (8 exons, 5 coding exons):
4 GGTCAGTACCCAGGAGTGG CACTTCTCAGAGCCTGGCC
5 GCTGGTGCATCAGGCTGG CACTTTGGGAGGACGACG
6 GTGCTGGGATTTTAGGTGTG CTCTAGGCTCAGAGTAAAGC
7 CTCCCAGGTGAGGCTGGAC GGCTGAGAAAGCAGGGGTGG
8 GCGAGTGTGGACTAAATGGCC GCTGTCCTCGGTCTGGAG
RDH14 (2 exons):
1.1 GTTCCGGTAAGGCGGCGG ACCCGCCGCCTCCTCGGC
1.2 CTACTGCGCCTGGGAGCG TCCCTCGCGGCTCAGCCCCA
2.1 GTGTTCTTAATAATTCTGCC ACAATACCAGGATGCAACAC
2.2 GCTTTTGTTATAGCCGGAGC CACAGATATAACTGATATGCAG
was initially similar to that of patients with LCA har-
boring RPE65 mutations—namely, mild or no hyper-
opia (or even mild myopia), as well as pigmentary de-
posits in the peripheral retina followed by a transient
improvement of visual acuity (VA) that could reach 1/
10 to 2/10 (or more), prompting one to even question
the diagnosis of LCA. In patients with RPE65 muta-
tions, this transient improvement could last for 115
years, whereas it lasted !10 years in the eight patients
with RDH12 mutations (and !5 years in two of eight
families). Finally, this severe and rapid progression of
the disease was consistently associated with develop-
ment of a large and severe macular atrophy in patients
carrying RDH12 mutations.
Discussion
The rod and cone photoreceptor cells of the retina utilize
a unique photosensitive vitamin A analog (11-cis retinal)
to absorb photons and initiate the process of phototrans-
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Figure 1 Pedigrees and segregation analysis of RDH12 disease-causing mutations in eight families with LCA
duction. Dietary vitamin A (all-trans retinal) is converted
into the 11-cis retinal photoactive chromophore in the
RPE, whereas the reception of photons occurs in the outer
segments of photoreceptors. The cycling of retinoid an-
alogs between these two cell types is deﬁned as the “visual
cycle.” Mutations in genes encoding several proteins in-
volved in this process have been shown to cause auto-
somal recessive retinal dystrophies—namely, (1) retinal-
dehyde-binding protein 1 (RLBP1) in RP and retinitis
punctata albescens; (2) the fourth member of the A sub-
family of the ATP-binding cassette superfamily (ABCA4)
in Stargardt disease, fundus ﬂavimaculatus,RP, and cone-
rod dystrophy (CRD); (3) 11-cis retinol dehydrogenase
(RDH5) in fundus albipunctatus; (4) LRAT in early-onset
severe RP; and (5) RPE65 in early-onset severe RP and
in the congenital severe yet progressive rod-cone dystro-
phy form of LCA (Hanein et al. 2004; for review, see
Haeseleer et al. 2002; Kuksa et al. 2003; Thompson and
Gal 2003).
Because a gene encoding a protein of the visual cycle,
RPE65, accounts for ∼6% of patients with LCA in our
series (Hanein et al. 2004), we hypothesized that a frac-
tion of hitherto unexplained LCA cases could be as-
cribed to genes encoding other proteins of the visual
cycle. Here, we report on nonsense or missense muta-
tions and frameshift deletions of the photoreceptor-
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Table 2
RDH12 Mutations, Silent Polymorphisms, and Benign Variants Identiﬁed in
Patients Affected with LCA
Type of Change, Family,
and Allele Number Exon Base Change
Predicted Amino
Acid Change
Mutations:
Family 1:
1 2 c.184CrT p.Arg62X
2 2 c.152TrA p.Ile51Asn
Family 2:
1 4 c.379GrT p.Gly127X
2 3 c.295CrA p.Leu99Ile
Family 3:
1 6 c.806-810delCCCTG p.Ala269fsX270
2 6 c.687CrG p.Pro230Ala
Family 4:
1 6 c.806-810delCCCTG p.Ala269fsX270
2 5 c.451CrA p.His151Asn
Family 5:
1 5 c.451CrG p.His151Asp
2 5 c. 451CrG p.His151Asp
Family 6:
1 5 c.523TrC p.Ser175Pro
2 6 c.677ArG p.Tyr226Cys
Family 7:
1 6 c.806-810delCCCTG p.Ala269fsX270
2 5 c. 6581GrA Aberrant splicing
Family 8:
1 6 c.806-810delCCCTG p.Ala269fsX270
2 6 c.806-810delCCCTG p.Ala269fsX270
Silent polymorphisms:
Family 1 5 c.482ArG p.Gln161Arg
Family 2 Intron 3 18760GrA …
Family 3 Intron 3 18754ArT …
Family 4 Intron 3 18814insT …
Family 5 Intron 5 44824ArG …
Family 6 Intron 6 65925TrA …
speciﬁc RDH12 gene in 8/44 patients with LCA affected
with the congenital severe yet progressive rod-cone dys-
trophy form of LCA (group B).
Most interestingly, the course of the disease differed
from that in patients harboring mutations in other
LCA genes. Indeed, unlike RPE65 or TULP1 muta-
tions, RDH12 mutations caused a severe macular at-
rophy leading to a severe visual loss before the end of
the 2nd decade of life. Moreover, unlike patients with
CRB1, they displayed mild or no hyperopia (Hanein
et al. 2004). Interestingly, no mutation was found in
patients with LCA who were affected with the con-
genital severe stationary cone-rod dystrophy form of
the disease (group A).
The RDH12 gene maps to chromosome 14q23, 8Mb
from the LCA3 locus (Stockton et al. 1998; University
of California Santa Cruz Genome Bioinformatics Web
site). One cannot exclude, therefore, RDH12 as the dis-
ease gene in the large consanguineous family of Arabian
origin that deﬁned the LCA3 locus. Indeed, several ex-
amples of gene location reassignment have recently been
reported (e.g., RP15 [MIM 300029]), and clinical ﬁnd-
ings reported in the LCA3 family are similar to those
in patients with RDH12 mutations: both displayed
moderate hypermetropia with fundus evidence of dif-
fuse bone spicule clumps in the mid and far retina and
macular atrophy (VA was poor but could be evaluated
as !2/500 [Stockton et al. 1998]).
Unlike RPE65, RDH12 is speciﬁcally expressed in
photoreceptor cells (Haeseleer et al. 2002). It has re-
cently been suggested that RDH12 might play a pivotal
role in the formation of 11-cis retinal from 11-cis ret-
inol, during regeneration of cone visual pigments (Hae-
seleer et al. 2002). The involvement of RDH12 in a
dynamic process (the regeneration of retinal) could ac-
count for the progressive nature of the disease, which
contrasts with the congenital severe stationary cone-rod
dystrophy form of LCA ascribed to the GUCY2D,
AIPL1, or RPGRIP1 genes (group A). In addition, the
Figure 2 Amino acid sequences of human and mouse RDH12 and of human RDH8, RDH10, RDH11, RDH13, and RDH14, deduced
from cDNA sequences (GenBank accession numbers BC025724, BC016204, NM_015725, BC067131, BC011727, BC009881, and BC009830,
respectively) and conservation of amino acids mutated in patients with LCA.
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Table 3
Silent Polymorphisms and Benign Variants Identiﬁed in LRAT,
RDH8,RDH10, RDH11, RDH13, and RDH14
Gene and
Family
Number Exon Base Change
Predicted
Amino Acid
Change
Frequency
(%)
LRAT:
1 2 c.525TrG p.Ser175Pro 3
RDH8:
1 2 c.237TrC p.Cys79Cys 1
2 3 c.408CrG p.His136Gln 35
RDH10:
1 1 c.133GrA None 1
RDH11:
1 5 c.628ArG p.Ile210Val 1
RDH13:
1 4 c.63CrT p.Asn21Asn 1
2a 4 c.63CrA p.Asn21Lys
2a 4 c.64GrA p.Ala22Asn 11
2a Intron 5 c.12742CrT
3 6 c.427CrT p.Leu143Leu 2
4 8 c.651CrG p.Phe217Leu 3
5 8 c.771CrA p.Pro257Pro 2
RDH14:
1 2 c.855TrC p.Thr285Thr 8
2 2 c.838GrA p.Val280Ile 1
a Three nucleotide changes were found on the same RDH13 allele;
the frequency value (11%) is for all three combined.
role of RDH12 in cones might explain why loss of visual
acuity is the most progressive feature of the disease.
In conclusion, the congenital severe yet progressive
rod-cone dystrophy form of LCA results from an im-
pairment of the visual cycle in 10.5% of cases. To date,
the treatment of animal models lacking RPE65 has been
the subject of intense interest. Promising results have
already been reported through use of either gene re-
placement (for review, see Bennett 2004) or pharma-
ceutical delivery of 9-cis retinal, a functional analog of
11-cis retinal (Van Hooser et al. 2000, 2002). Although
photoreceptor cells appear to be less accessible thanRPE
cells to therapeutic intervention, one can expect that
11-cis retinal to the retina would rescue the enzyme
deﬁciency in future RDH12-deﬁcient animal models.
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